文献速递真菌感染艾滋病与性传播感染

脑内细胞因子反应能否解释地塞米松在HIV相关隐球菌脑膜炎中的有害效应?

Do Intracerebral Cytokine Responses Explain the Harmful Effects of Dexamethasone in Human Immunodeficiency Virus-associated Cryptococcal Meningitis?
PubMed 文献 · Clin Infect Dis · 2019-01-01

CryptoDex试验显示地塞米松在HIV相关隐球菌脑膜炎中导致临床结局更差并减缓真菌清除。本研究分析脑脊液细胞因子浓度,发现地塞米松加快TNF-α浓度下降速率,且该下降与真菌清除减慢相关;LTA4H基因型对结局或地塞米松反应无显著影响。

要点

  • 地塞米松加快脑脊液TNF-α浓度下降速率,与真菌清除减慢相关。
  • LTA4H基因型对结局及地塞米松反应无显著影响。
  • 基线干扰素γ浓度较高与更好的临床结局相关。

核心结论

  • 地塞米松可能通过加快TNF-α浓度下降速率来减缓真菌清除并恶化结局。

研究设计与样本

  • 纳入来自越南、泰国和乌干达的参与者,分析治疗第一周脑脊液细胞因子浓度。
  • 使用Luminex系统测量干扰素γ、TNF-α、GM-CSF、MCP-1、MIP-1α及白细胞介素6、12p70、8、4、10、17。
  • 基于启动子区单核苷酸多态性rs17525495确定LTA4H基因型。
  • 采用混合效应模型评估地塞米松对细胞因子动态的影响及细胞因子动态与真菌清除的关联。
  • 采用Cox回归模型评估LTA4H基因型对结局的影响。

主要发现

  • 地塞米松加快TNF-α浓度下降速率:-0.13 log2pg/mL/d(95%CI,-.22至-.06 log2pg/mL/d;P = .03)。
  • TNF-α下降速率与真菌清除减慢相关:相关系数-0.62(95%CI,-.83至-.26)。
  • LTA4H基因型对结局或地塞米松治疗反应无统计学显著影响。
  • 更好的临床结局与更高的基线干扰素γ浓度相关。

临床怎么用

  • HIV相关隐球菌脑膜炎应避免使用地塞米松,因其可能减缓真菌清除并恶化结局。
  • 监测脑脊液TNF-α动态可能有助于理解地塞米松的有害机制,但尚不推荐常规检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The CryptoDex trial showed that dexamethasone caused poorer clinical outcomes and slowed fungal clearance in human immunodeficiency virus-associated cryptococcal meningitis. We analyzed cerebrospinal fluid (CSF) cytokine concentrations from participants over the first week of treatment to investigate mechanisms of harm and test 2 hypotheses: (1) dexamethasone reduced proinflammatory cytokine concentrations, leading to poorer outcomes and (2) leukotriene A4 hydrolase (LTA4H) genotype influenced the clinical impact of dexamethasone, as observed in tuberculous meningitis. METHODS: We included participants from Vietnam, Thailand, and Uganda. Using the Luminex system, we measured CSF concentrations of the following: interferon γ, tumor necrosis factor (TNF) α, granulocyte-macrophage colony-stimulating factor, monocyte chemoattractant 1, macrophage inflammatory protein 1α, and interleukin 6, 12p70, 8, 4, 10, and 17. We determined the LTA4H genotype based on the promoter region single-nucleotide polymorphism rs17525495. We assessed the impact of dexamethasone on cytokine concentration dynamics and the association between cytokine concentration dynamics and fungal clearance with mixed effect models. We measured the influence of LTA4H genotype on outcomes with Cox regression models. RESULTS: Dexamethasone increased the rate TNF-α concentration's decline in (-0.13 log2pg/mL/d (95% confidence interval, -.22 to -.06 log2pg/mL/d; P = .03), which was associated with slower fungal clearance (correlation, -0.62; 95% confidence interval, -.83 to -.26). LTA4H genotype had no statistically significant impact on outcome or response to dexamethasone therapy. Better clinical outcomes were associated with higher baseline concentrations of interferon γ. CONCLUSIONS: Dexamethasone may slow fungal clearance and worsen outcomes by increasing TNF-α concentration's rate of decline.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Beardsley J, Hoang NLT, Kibengo FM, et al. Do Intracerebral Cytokine Responses Explain the Harmful Effects of Dexamethasone in Human Immunodeficiency Virus-associated Cryptococcal Meningitis? Clin Infect Dis. 2019. PMID: 30169607. doi:10.1093/cid/ciy725

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。